Herein, we provide evidence that TRIM4 is downregulated in TAM‐resistant breast cancer cells, and that the loss of TRIM4 expression is associated with hormone receptor‐independent phenotypes, including TAM resistance and triple‐negative breast cancer (TNBC). Here, NR4A1 is linked to breast carcinoma.